menu search

Analysts think sales of abbvie's migraine drugs will each top $2 billion

Two new migraine treatments from AbbVie Inc. ( ABBV , Financial) could help offset any headaches caused...

January 31, 2022, 4:48 pm

Analysts think sales of abbvie's migraine drugs will each top $2 billion

Two new migraine treatments from AbbVie Inc. ( ABBV , Financial) could help offset any headaches caused...

January 31, 2022, 4:48 pm

Analysts think sales of abbvie's migraine drugs will each top $2 billion

Two new migraine treatments from AbbVie Inc. ( ABBV , Financial) could help offset any headaches caused...

January 31, 2022, 4:48 pm

Braxia scientific says it continues psychedelic-based clinical research trials to support future drug development

Braxia Scientific Corp. (CSE:BRAX, OTC:BRAXF) said that its scientists continue to carry out multiple psychedelic-based clinical research trials, addi...

January 31, 2022, 8:58 am

Braxia scientific says it continues psychedelic-based clinical research trials to support future drug development

Braxia Scientific Corp. (CSE:BRAX, OTC:BRAXF) said that its scientists continue to carry out multiple psychedelic-based clinical research trials, addi...

January 31, 2022, 8:58 am

Braxia scientific says it continues psychedelic-based clinical research trials to support future drug development

Braxia Scientific Corp. (CSE:BRAX, OTC:BRAXF) said that its scientists continue to carry out multiple psychedelic-based clinical research trials, addi...

January 31, 2022, 8:58 am

Arcellx sets ipo terms, looks to raise up to $140.3 million

Arcellx Inc. ACLX, has set terms for its initial public offering, in which the Maryland-based biotechnology company, which is developing cancer ...

January 31, 2022, 8:30 am

Arcellx sets ipo terms, looks to raise up to $140.3 million

Arcellx Inc. ACLX, has set terms for its initial public offering, in which the Maryland-based biotechnology company, which is developing cancer ...

January 31, 2022, 8:30 am

Arcellx sets ipo terms, looks to raise up to $140.3 million

Arcellx Inc. ACLX, has set terms for its initial public offering, in which the Maryland-based biotechnology company, which is developing cancer ...

January 31, 2022, 8:30 am

Down 57% in a month, is there more pain for tg therapeutics stock?

The stock price of TG Therapeutics (NASDAQ: TGTX), a commercial stage biopharmaceutical company focused on the development of novel ...

January 31, 2022, 5:00 am

Down 57% in a month, is there more pain for tg therapeutics stock?

The stock price of TG Therapeutics (NASDAQ: TGTX), a commercial stage biopharmaceutical company focused on the development of novel ...

January 31, 2022, 5:00 am

Down 57% in a month, is there more pain for tg therapeutics stock?

The stock price of TG Therapeutics (NASDAQ: TGTX), a commercial stage biopharmaceutical company focused on the development of novel ...

January 31, 2022, 5:00 am

Imugene secures japanese grant notice for oncolytic virotherapy cf33 patent

Imugene Ltd (ASX:IMU, OTC:IUGNF) has received a notice of grant from the Japanese Patent Office for Patent Application number 2019-507161 which protec...

January 30, 2022, 7:52 pm

Imugene secures japanese grant notice for oncolytic virotherapy cf33 patent

Imugene Ltd (ASX:IMU, OTC:IUGNF) has received a notice of grant from the Japanese Patent Office for Patent Application number 2019-507161 which protec...

January 30, 2022, 7:52 pm

Imugene secures japanese grant notice for oncolytic virotherapy cf33 patent

Imugene Ltd (ASX:IMU, OTC:IUGNF) has received a notice of grant from the Japanese Patent Office for Patent Application number 2019-507161 which protec...

January 30, 2022, 7:52 pm

Enveric biosciences to participate in upcoming investor conferences in february 2022

NAPLES, Fla. , Jan. 27, 2022 /PRNewswire/ - Enveric Biosciences (NASDAQ: ENVB) ("Enveric" or the "Company"), a patient-centric biotechnology company...

January 27, 2022, 7:30 am

Enveric biosciences to participate in upcoming investor conferences in february 2022

NAPLES, Fla. , Jan. 27, 2022 /PRNewswire/ - Enveric Biosciences (NASDAQ: ENVB) ("Enveric" or the "Company"), a patient-centric biotechnology company...

January 27, 2022, 7:30 am

Enveric biosciences to participate in upcoming investor conferences in february 2022

NAPLES, Fla. , Jan. 27, 2022 /PRNewswire/ - Enveric Biosciences (NASDAQ: ENVB) ("Enveric" or the "Company"), a patient-centric biotechnology company...

January 27, 2022, 7:30 am

Alector, inc: a newer biotech company with big potential

Biotech companies have seen an economic boom lately thanks to the COVID-19 Pandemic and the need for effective ...

January 26, 2022, 5:47 am

Alector, inc: a newer biotech company with big potential

Biotech companies have seen an economic boom lately thanks to the COVID-19 Pandemic and the need for effective ...

January 26, 2022, 5:47 am


Search within

Pages Search Results: